Immune Reconstitution
Immune Reconstitution
批准号:
7965394
负责人:
Ronald Gress
金额:
$161.98万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AcuteAddressAdultAgingAllogenicAndrogensAreaBiologyCD4 Positive T LymphocytesCD8B1 geneCell Cycle RegulationCell surfaceClinical TrialsDoseEpithelial CellsGenerationsGenesGoalsHematopoietic Stem Cell TransplantationHomeostasisHumanImmuneImmune systemInsulin-Like Growth Factor IInterleukin-7MaintenanceMalignant NeoplasmsMapsMediatingModelingMolecularMusNatural regenerationPathway interactionsPatientsPeripheralPhenotypePopulationRegulationResearchRoleSignal TransductionStromal CellsT-LymphocyteThymocyte DevelopmentThymus GlandTimeVaccinesWorkcancer therapynotch proteinreconstitutionsenescencethymocyte
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The biology of reconstitution of T cell populations following acute loss has, in the past, been incompletely characterized. Using murine models, we first identified two primary pathways of T cell immune reconstitution, the classic, thymic-dependent pathway, and a second, thymic-independent pathway. We then identified T cell surface markers which allowed identification, by phenotyping of reconstituted T cell populations, of the pathways which had given rise to them, and then applied this information to the characterization of T cell reconstitution in patients. Initial work established the applicability of this approach to the study of T cell population regeneration in humans. Recent work verified validity of the approach and established the course of T cell immune reconstitution in adult humans over time for each of the two primary pathways. This work also showed an essential role for the thymus in regenerating CD4+ T cells quantitatively. CD8+ T cells depend more strongly on peripheral expansion for immune reconstitution. Both CD4+ and CD8+ T cells require thymic activity for maintenance or generation of repertoire diversity. These findings have led in turn to a research emphasis on understanding mechanisms which control thymic function, and new treatments, including vaccine strategies, to treat cancer in the setting of a regenerating immune system. Four models of thymic regulation have been developed; this work has progressed to the developoment of two new project areas of research -- one focused on points of regulation of thymus function and one on introducing agents into clinical trials. The work addressed in this project has also led to efforts in investigating IL-7 effects on the maturation of thymocytes. We have identified IL-7 as a negative regulator of thymopoiesis as well as being essential for thymocyte development. These dual roles are dose dependent and negative regulation at higher concentrations is mediated through control of Notch signaling -- which is central to T/B lineage commitment. Additionally, we have worked to identify genes which might regulate the thymus, and have characterized a gene called SPATIAL which is a negative regulator acting within the stromal cell compartment. It appears to exert its effect through control of cell cycle, specifically through regulation of the Nedd8 pathway. The cellular and molecular mechanisms by which androgen signaling blockade and IGF-1 modulate thymus function were characterized and map points of regulation to the epithelial cell compartment of the thymus.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ETIB Clinical Research Core
-
批准号:8763801
-
项目类别:
-
资助金额:$226.87万
-
财政年份:--
-
负责人:Ronald Gress
-
依托单位:
Immune Reconstitution
-
批准号:8937763
-
项目类别:
-
资助金额:$138.08万
-
财政年份:--
-
负责人:Ronald Gress
-
依托单位:
ETIB Clinical Research Core
-
批准号:8938515
-
项目类别:
-
资助金额:$162.09万
-
财政年份:--
-
负责人:Ronald Gress
-
依托单位:
ETIB Clinical Trials
-
批准号:10702441
-
项目类别:
-
资助金额:$333.48万
-
财政年份:--
-
负责人:Ronald Gress
-
依托单位:
Transplant Models
-
批准号:7733365
-
项目类别:
-
资助金额:$70.74万
-
财政年份:--
-
负责人:Ronald Gress
-
依托单位:
ETIB Clinical Research Core
-
批准号:10703100
-
项目类别:
-
资助金额:$130.78万
-
财政年份:--
-
负责人:Ronald Gress
-
依托单位:
Immune Reconstitution
-
批准号:10262110
-
项目类别:
-
资助金额:$224.14万
-
财政年份:--
-
负责人:Ronald Gress
-
依托单位:
Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas
-
批准号:8937868
-
项目类别:
-
资助金额:$17.76万
-
财政年份:--
-
负责人:Ronald Gress
-
依托单位:
Immune Reconstitution
-
批准号:9556308
-
项目类别:
-
资助金额:$130.34万
-
财政年份:--
-
负责人:Ronald Gress
-
依托单位:
Immune Reconstitution
-
批准号:8552724
-
项目类别:
-
资助金额:$121.19万
-
财政年份:--
-
负责人:Ronald Gress
-
依托单位:
Immune Reconstitution
-
批准号:8349037
-
项目类别:
-
资助金额:$116.68万
-
财政年份:--
-
负责人:Ronald Gress
-
依托单位:
ETIB Clinical Trials
-
批准号:8552903
-
项目类别:
-
资助金额:$257.52万
-
财政年份:--
-
负责人:Ronald Gress
-
依托单位:
Immune Reconstitution
-
批准号:8763129
-
项目类别:
-
资助金额:$106.76万
-
财政年份:--
-
负责人:Ronald Gress
-
依托单位:
ETIB Clinical Trials
-
批准号:8937907
-
项目类别:
-
资助金额:$162.09万
-
财政年份:--
-
负责人:Ronald Gress
-
依托单位:
ETIB Clinical Trials
-
批准号:10014492
-
项目类别:
-
资助金额:$116.13万
-
财政年份:--
-
负责人:Ronald Gress
-
依托单位:
Immune Reconstitution
-
批准号:8157334
-
项目类别:
-
资助金额:$159.57万
-
财政年份:--
-
负责人:Ronald Gress
-
依托单位:
Branch Clinical Research Core
-
批准号:7733371
-
项目类别:
-
资助金额:$326.48万
-
财政年份:--
-
负责人:Ronald Gress
-
依托单位:
ETIB Clinical Research Core
-
批准号:9344213
-
项目类别:
-
资助金额:$152.76万
-
财政年份:--
-
负责人:Ronald Gress
-
依托单位:
ETIB Clinical Trials
-
批准号:8349249
-
项目类别:
-
资助金额:$247.94万
-
财政年份:--
-
负责人:Ronald Gress
-
依托单位:
Transplant Models
-
批准号:8349246
-
项目类别:
-
资助金额:$116.68万
-
财政年份:--
-
负责人:Ronald Gress
-
依托单位:
海外基金